Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment complete in ERYtech Pharma's phase II Graspa trial in acute lymphoblastic leukemia

March 11, 2011

Plexxikon begins phase II trial of PLX-3397 in Hodgkin's lymphoma

March 11, 2011

Novartis presents novel inhibitors of hepatocyte growth factor receptor

March 11, 2011

Cell Therapeutics reports final design of pivotal pixantrone trial

March 11, 2011

Genus Oncology's GO-203-2c receives FDA orphan drug status in pancreatic cancer

March 11, 2011

Tyroxenex's X-82 enters phase I trial in advanced solid tumors

March 10, 2011

Phase II trial of PD-0332991 in advanced NSCLC is under way

March 10, 2011

Pfizer's axitinib receives European orphan drug status in renal cell carcinoma

March 10, 2011

Combination of Chk1 inhibitor and gemcitabine shows promise in model of colon cancer

March 10, 2011

Aeterna Zentaris and Yakult Honsha enter exclusive agreement for perifosine in Japan

March 10, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...